September 15, 2026 · Journal of hepatology · DOI: 10.1016/j.jhep.2026.07.012

The use of locoregional therapies in cholangiocarcinoma

Listen to this summary

This literature review investigates the role of locoregional therapies in managing unresectable or advanced cholangiocarcinoma (CCA), particularly intrahepatic (iCCA) and perihilar CCA (pCCA). The authors aim to evaluate the clinical outcomes of various locoregional treatments compared to the standard systemic chemotherapy and immunotherapy, highlighting the need for individualized treatment strategies until more robust evidence from randomized controlled trials is available. The findings suggest a trend towards integrating locoregional therapies with standard care to improve patient outcomes.

Alejandra Méndez Romero, Thomas C Zwaan, Suus Y van Loosbroek, Jens Ricke, Bas Groot Koerkamp

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play